Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Investigation of the Mutated Antimicrobial Peptides to Inhibit Ace2, Tmprss2 and Grp78 Receptors of Sars-Cov-2 and Angiotensin Ii Type 1 Receptor (At1r) As Well As Controlling Covid-19 Disease
Hamid Bakherad
Hamid Bakherad

Assistant Professor of Pharmaceutical Biotechnology

Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences

Isfahan University of Medical Sciences

Related Documents
1. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
All Documents
1. Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents, Journal of Molecular Structure (2025)
2. Covid-19 Prevention and Treatment by Targeting Proteins: An Experience to Fight Emerging Diseases, Current Molecular Medicine (2024)
3. Covid-19 Prevention and Treatment by Targeting Proteins: An Experience to Fight Emerging Diseases, Current Molecular Medicine (2024)
4. In Silico Designing and Optimization of Anti-Epidermal Growth Factor Receptor Scaffolds by Complementary-Determining Regions-Grafting Technique, Quantitative Biology (2024)
5. Investigating the Effect of Cgrp78 Vaccine Against Different Cancer Cells and Its Role in Reducing Melanoma Metastasis, Research in Pharmaceutical Sciences (2024)
6. Investigating the Effect of Cgrp78 Vaccine Against Different Cancer Cells and Its Role in Reducing Melanoma Metastasis, Research in Pharmaceutical Sciences (2024)
7. Synthesis, and Molecular Docking Studies of Novel 1,2,3-Triazoles-Linked Pyrazole Carboxamides As Significant Anti-Microbial and Anti-Cancer Agents, Results in Chemistry (2024)
8. A Novel Approach to Enhance the Performance of Kallikrein 6 Enzyme Using Pichia Pastoris Gs115 As a Host, Research in Pharmaceutical Sciences (2023)
9. Anti-Egfr Bioengineered Bacterial Outer Membrane Vesicles As Targeted Immunotherapy Candidate in Triple-Negative Breast Tumor Murine Model, Scientific Reports (2023)
10. Biochemical and Molecular Characterization of Novel Keratinolytic Protease From Bacillus Licheniformis (Krlr1), Frontiers in Microbiology (2023)
11. Introduction of a New Recombinant Vaccine Based on Grp78 for Breast Cancer Immunotherapy and Evaluation in a Mouse Model, BioImpacts (2023)
12. Introduction of a New Recombinant Vaccine Based on Grp78 for Breast Cancer Immunotherapy and Evaluation in a Mouse Model, BioImpacts (2023)
13. Production of Recombinant E.Coli Asparaginase on a Laboratory Scale, Journal of Isfahan Medical School (2023)
14. Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole-Tetrahydropyrimidinone(Thione) Hybrid Scaffolds As Urease Inhibitors, Chemistry and Biodiversity (2023)
15. Synthesis, Biological Assessment, and Computational Investigations of Nifedipine and Monastrol Analogues As Anti-Leishmanial Major and Anti-Microbial Agents, Molecular Diversity (2023)
16. Design, Synthesis, and in Silico Studies of Tetrahydropyrimidine Analogs As Urease Enzyme Inhibitors, Archiv der Pharmazie (2022)
17. In Silico and in Vitro Studies of Thiosemicarbazone-Indole Hybrid Compounds As Potent Α-Glycosidase Inhibitors, Computational Biology and Chemistry (2022)
18. In Silico and in Vitro Studies of Thiosemicarbazone-Indole Hybrid Compounds As Potent Α-Glycosidase Inhibitors, Computational Biology and Chemistry (2022)
19. Nanobodies; New Molecular Instruments With Special Specifications for Targeting, Diagnosis and Treatment of Triple-Negative Breast Cancer, Cancer Cell International (2022)
20. Outlook of Therapeutic and Diagnostic Competency of Nanobodies Against Sars-Cov-2: A Systematic Review, Analytical Biochemistry (2022)
21. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Evaluation of a Cationic Antimicrobial Peptide As the New Antibiotic Candidate to Treat Staphylococcus Aureus Keratitis, International Journal of Peptide Research and Therapeutics (2021)
23. Isolation and Characterization of a Novel Nanobody for Detection of Grp78 Expressing Cancer Cells, Biotechnology and Applied Biochemistry (2021)
24. Nanobodies, the Potent Agents to Detect and Treat the Coronavirus Infections: A Systematic Review, Molecular and Cellular Probes (2021)
25. Nanobodies: A Tool to Open New Horizons in Diagnosis and Treatment of Prostate Cancer, Cancer Cell International (2021)
26. Engineering an Anti-Granulocyte Colony Stimulating Factor Receptor Nanobody for Improved Affinity, Life Sciences (2020)
27. Engineering an Anti-Granulocyte Colony Stimulating Factor Receptor Nanobody for Improved Affinity, Life Sciences (2020)
28. Expression of Recombinant G-Csf Receptor Domains and Their Inhibitory Role on G-Csf Function, Research in Pharmaceutical Sciences (2020)
29. Expression of Recombinant G-Csf Receptor Domains and Their Inhibitory Role on G-Csf Function, Research in Pharmaceutical Sciences (2020)
30. Identification and in Vitro Characterization of Novel Nanobodies Against Human Granulocyte Colony-Stimulating Factor Receptor to Provide Inhibition of G-Csf Function, Biomedicine and Pharmacotherapy (2017)
31. Structure Prediction, Expression, and Antigenicity of C-Terminal of Grp78, Biotechnology and Applied Biochemistry (2017)